Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK 826

Known as: MK-826 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Abstractβ-Lactam antibiotics represent the most commonly prescribed antibacterial agents. New β-lactams have been introduced… Expand
  • figure 1
  • table I
Is this relevant?
Review
2002
Review
2002
Ertapenem sodium (trade name Invanz, also designated as MK-0826, MK-826 and L-749345), manufactured by Merck & Co., Inc. is a… Expand
Is this relevant?
Review
2001
Review
2001
Beta-lactam antibiotics represent the most commonly prescribed antibacterial agents. New beta-lactams have been introduced… Expand
Is this relevant?
2001
2001
Publisher Summary This chapter examines the various developments in antibacterial research. Significant effort continues to be… Expand
Is this relevant?
Review
2000
Review
2000
During the last few decades, several carbapenems have been developed. The major characteristic of the newer drugs, such as MK-826… Expand
Is this relevant?
2000
2000
The activity of MK-826 was compared to the activities of cefoxitin, ceftriaxone, imipenem, and meropenem against 363 gram… Expand
Is this relevant?
1999
1999
After intravenous administration of MK-826, a new carbapenem antibiotic, the compound exhibited nonlinear pharmacokinetics in… Expand
Is this relevant?
1998
1998
MK-826 (formerly L-749,345), is a potent 1-beta-methyl carbapenem with a long half-life and broad spectrum of activity. This… Expand
Is this relevant?